PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2009 | 4 | 3 | 369-373
Article title

Arterial embolisation and coiling for high-output heart failure and pulmonary hypertension ınduced by hepatic arteriovenous fistula in a patient with hereditary hemorrhagic telengiectasia

Content
Title variants
Languages of publication
EN
Abstracts
EN
Hereditary hemorrhagic telangiectasia (HHT) is a genetic vascular disorder characterised by epistaxis, telangiectases, and visceral arteriovenous malformations. Hyperdynamic blood flow associated with arteriovenous malformations may lead to pulmonary hypertension, global heart failure, and valvular insufficiencies. We report a patient who had HHT with severe heart failure (New York Heart Association [NYHA] class III-IV) and pulmonary hypertension caused by an hepatic arteriovenous fistula. After successful transarterial embolisation of the right branch of the hepatic artery with polyvinyl alcohol (PVA) particles and coils, 4 to 7 mm in size, the patient was discharged with functional class II (NYHA) heart failure.
Publisher

Journal
Year
Volume
4
Issue
3
Pages
369-373
Physical description
Dates
published
1 - 9 - 2009
online
3 - 7 - 2009
Contributors
  • Cardiology Department, Gazi University Faculty of Medicine, 06500, Ankara, Turkey
  • Cardiology Department, Gazi University Faculty of Medicine, 06500, Ankara, Turkey, gtacoy@gmail.com
author
  • Radiology Department, Gazi University Faculty of Medicine, 06500, Ankara, Turkey
  • Gastroenterology Department, Gazi University Faculty of Medicine, 06500, Ankara, Turkey
author
  • Cardiology Department, Gazi University Faculty of Medicine, 06500, Ankara, Turkey
References
  • [1] Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telengiectasia (Osler-Weber-Rendu disease). New insights in pathogenesis, complications, and treatment. Arch Intern Med 156:714–719, 1996 http://dx.doi.org/10.1001/archinte.156.7.714[Crossref]
  • [2] Garcia-Tsao G, Korzenik JR, Young L, Henderson KJ, Jain D, Byrd B, Pollak JS, White RI (2000) Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 343:931–936 http://dx.doi.org/10.1056/NEJM200009283431305[Crossref]
  • [3] Shovlin CL, Guttmacher AE, Buscarini E, Faughan ME, Hyland RH, Westermann CJ, et al: Diagnostic cirteria for hereditary hemorrhagic telengectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000;91:66–67 http://dx.doi.org/10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P[Crossref]
  • [4] Bourgeois N, Delcour C, Deviere J, Francois A, Lambert M, Crener M. Osler-Weber-Rendu disease associated with hepatic involvement and high-output heart failure. J Clin Gastroenterol 1990;12:236–8 http://dx.doi.org/10.1097/00004836-199004000-00030[Crossref]
  • [5] Chavan A, Galanski M, Wagner S, et al. Hereditary hemorrhagic telangiectasia:effective protocol for embolization of hepatic vascular malformationsexperience in five patients. Radiology 1998;209:735–9
  • [6] Roman CF, Cha SD, Incarvito J, Cope C, Maranhao V. Transcatheter embolization of hepatic arteriovenous fistula in Osler-Weber-Rendu disease: a case report. Angiology 1987;38:484–8 http://dx.doi.org/10.1177/000331978703800610[Crossref]
  • [7] Göthlin JH, Nordgard K, Johnson K, Nyman U. Hepatic telangiectasia in Osler’s disease treated with arterial embolization. Report of 2 cases. Eur J Radiol 1982;2:27–30
  • [8] Allison DJ, Jordan H, Hennesy O. Therapeutic embolization of the hepatic artery. A review of 75 procedures. Lancet 1985;1:595–9 http://dx.doi.org/10.1016/S0140-6736(85)92142-7[Crossref]
  • [9] Whiting JH Jr, Morton KA, Datz FL, Patch GG, Miller FJ Jr. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: case report. J Nucl Med 1992;33:260–2
  • [10] Larson AM. Liver disease in hereditary hemorrhagic telangiectasia. J Clin Gastroenterol 2003;36:149–158 http://dx.doi.org/10.1097/00004836-200302000-00013[Crossref]
  • [11] Spurny OM, Pierce JA. Cardiac output in systemic arteriovenous fistula complicated by heart failure. Am Heart J 1961;61:21–4 http://dx.doi.org/10.1016/0002-8703(61)90512-9[Crossref]
  • [12] Whiting JH, Morton KA, Datz FL, Patch GG, Miller FJ. Embolization of hepatic arteriovenous malformations using radiolabeled and nonradiolabeled polyvinyl alcohol sponge in a patient with hereditary hemorrhagic telangiectasia: Case report. J Nucl Med 1992;33:260–262
  • [13] Bonderman D, Nowotny R, Skoro-Sajer N, Adbrecht C, Lang IM. Bosentan therapy for pulmonary arterial hypertension associated with hereditary hemorrhagic telangiectasia. Eur J Clin Invest 2006;36Suppl 3:71–2 [Crossref][PubMed]
  • [14] Rigelsky CM, Jennings C, Lehtonen R, Minai OA, Eng C, Aldred MA. BMPR2 mutation in a patient with pulmonary arterial hypertension and suspected hereditary hemorrhagic telangiectasia. Am J Med Genet A, 2008; 1;146A:2551–6 [WoS]
  • [15] Garcia-Tsao G, Korzenik JR, Young L et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med 2000;343:931–6 http://dx.doi.org/10.1056/NEJM200009283431305[Crossref]
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.-psjd-doi-10_2478_s11536-009-0028-3
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.